SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ChemTrak
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: William Presti who wrote (18)10/14/1996 11:59:00 AM
From: DeadHead   of 48
 
William,

Thanks for taking the time to call and to keep us up to date. Did Ms. Carnegie say anything about the agreement with Merck to bundle their H. Pylori drug with CMTR's test kit? I expected to have heard something by now.

One word of caution. I've talked to their investor relations person last year about this time (I'm not sure if it was Ms. Carnegie, or not), and she too didn't understand why the stock price was so low. A month or so after our conversation, the priced continued to drop and settled down to about a third of its value. This proved to be a good buying opportunity, however.

Keep in mind that CMTR is a very volatile stock. Its ups and downs seem to be driven more by the speculators than investors. We are now entering into the tax-loss selling season, so you can count on stocks like CMTR to get driven way below their real value. Keep some cash available so you can snap up this stock at bargan-basement prices.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News